Suchergebnisse - "Chibana, Kenji"

PubPharm (17)

1

Identification of exhaled volatile organic compounds that characterize asthma phenotypes : A J-VOCSA study

enthalten in: Allergology international : official journal of the Japanese Society of Allergology | 2024

von Suzukawa, M. | Ohta, K. | Sugimoto, M. | +16

2

Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer : study protocol for ABRAID study (WJOG11919L)

enthalten in: Therapeutic advances in medical oncology | 2024

von Ozawa, Y. | Koh, Y. | Hase, T. | +7

3

Prophylactic treatment of dacomitinib-induced skin toxicities in epidermal growth factor receptor-mutated non-small-cell lung cancer : A multicenter, Phase II trial

enthalten in: Cancer medicine | 2023

von Iwasaku, M. | Uchino, J. | Chibana, K. | +16

4

Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers : A Nationwide Cohort Study in Japan (NHOM Asthma Study)

enthalten in: Allergology international : official journal of the Japanese Society of Allergology | 2023

von Suzukawa, M. | Ohta, K. | Fukutomi, Y. | +30

5

Prophylactic treatment of dacomitinib‐induced skin toxicities in epidermal growth factor receptor‐mutated non–small‐cell lung cancer : A multicenter, Phase II trial

enthalten in: Cancer Medicine | 2023

von Iwasaku, M. | Uchino, J. | Chibana, K. | +16

6

Clinical impact of amrubicin monotherapy in patients with relapsed small cell lung cancer : a multicenter retrospective study

enthalten in: Translational lung cancer research | 2022

von Uda, S. | Yamada, T. | Yoshimura, A. | +25

7

A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC : Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L)

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2021

von Yamaguchi, H. | Wakuda, K. | Fukuda, M. | +17

8

A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small cell lung cancer : treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L)

enthalten in: BMC cancer | 2020

von Wakuda, K. | Yamaguchi, H. | Kenmotsu, H. | +13

9

A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L)

enthalten in: BMC cancer | 2020

von Wakuda, K. | Yamaguchi, H. | Kenmotsu, H. | +13

10

A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L)

enthalten in: BMC cancer | 2020

von Wakuda, K. | Yamaguchi, H. | Kenmotsu, H. | +13